Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients With Moderate-to-Severe Plaque Psoriasis: 52-Week Data From the IXORA-S Trial. (2018). SKIN The Journal of Cutaneous Medicine, 2, S117. https://doi.org/10.25251/skin.2.supp.106